Recodep 12.5 mg is a medication that contains the active ingredient venlafaxine, which is classified as a serotonin-norepinephrine reuptake inhibitor (SNRI). It is primarily used to treat major depressive disorder, generalized anxiety disorder, and social anxiety disorder. By increasing the levels of serotonin and norepinephrine in the brain, Recodep helps to improve mood, alleviate anxiety, and enhance overall emotional well-being. The 12.5 mg dosage is often used for patients who may require a lower starting dose or those who are sensitive to medication. It is important for patients to follow their healthcare provider's instructions regarding dosage and administration to ensure effective treatment while minimizing potential side effects.